##### Table of Contents



---

---

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549




---



FORM 10-K/A

|                                            |  |                                                                                         
|------------------------------------------- |  | ----------------------------------------------------------------------------------------
|(Mark One)                                  |  |                                                                                         
|[X]                                         |  | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934    
|                                           
|For the fiscal year ended December 31, 2001
|                                           
|OR                                         
|                                           
|[   ]                                       |  | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______________ to _______________.

Commission file number: 000-22891

CORIXA CORPORATION

(Exact name of registrant as specified in its charter)


|                                                               |                                     
|-------------------------------------------------------------- | ------------------------------------
|Delaware                                                       | 91-1654387                          
|(State or other jurisdiction of
incorporation or organization) | (I.R.S. Employer
Identification No.)

1124 Columbia St., Suite 200
Seattle, WA 98104(Address of principal executive offices, including zip code)

Registrants telephone number, including area code: (206) 754-5711

Securities registered pursuant to Section 12(b) of the Act: None
Securities registered pursuant to Section 12(g) of the Act:
Common Stock, $0.001 par value per share

Indicate by check mark whether the Registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period than the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.    YES  [X]    NO  [   ]

Indicate by check mark if disclosure of delinquent filers pursuant to Item
405 of Regulation S-K is not contained herein, and will not be contained, to
the best of registrants knowledge, in definitive proxy or information
statements incorporated by reference in Part III of this Form 10-K or any
amendment to this Form 10-K.    [   ]

The aggregate market value of the voting stock held by non-affiliates of
the Registrant was approximately $405 million as of February 22, 2002, based
upon the closing sale price on the Nasdaq National Market reported for such
date. Shares of Common Stock held by each officer and director and by each
person who owns 5% or more of the outstanding Common Stock have been excluded
in that such persons may be deemed to be affiliates. This determination of
affiliate status is not necessarily a conclusive determination for other
purposes.

There were 41,587,801 shares of the registrants Common Stock outstanding
as of February 22, 2002.

DOCUMENTS INCORPORATED BY REFERENCE:

Part III incorporates information by reference from the Registrants Proxy
Statement for its 2002 Annual Meeting of Stockholders.



---

---

1



---

TABLE OF CONTENTS



|                  |  |  |  |  |  |  |  | 
|----------------- |  |  |  |  |  |  |  | 
|PART IV          
|SIGNATURES       
|INDEX TO EXHIBITS
|EXHIBIT 10.14    
|EX-10.42         
|EX-10.43         
|EXHIBIT 10.44    
|EXHIBIT 10.64    
|EXHIBIT 10.67    
|EXHIBIT 10.68    
|EXHIBIT 10.72    



---



##### Table of Contents



EXPLANATORY NOTE:

This amended annual report on Form 10-K/A is being filed for the purpose
of refiling certain exhibits in connection with a pending application for
confidential treatment, which was originally filed with our annual report on
Form 10-K on March 1, 2002. The redactions to these exhibits have been amended
in accordance with a revised application for confidential treatment filed
separately by Corixa with the Commission and concurrently with this amended
annual report. We have made no further changes to the previously filed Form
10-K.




PART IV

|        |     |                     |                                                                                                                                                                                                                                                                      |           |    
|------- | --- | ------------------- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | --------- | ---
|Exhibit |     |                     |                                                                                                                                                                                                                                                                      |          
|Number  |     | Exhibit Description |                                                                                                                                                                                                                                                                      | Reference
|        |     |                     |                                                                                                                                                                                                                                                                      |          
|3.      | 1   |                     | Amended and Restated Certificate of Incorporation of Corixa Corporation                                                                                                                                                                                              |           | (A)
|       
|       
|       
|       
|3.      | 2   |                     | Certificate of Designation of Series A Preferred Stock                                                                                                                                                                                                               |           | (E)
|       
|       
|       
|       
|3.      | 3   |                     | Certificate of Designation of Series B Preferred Stock                                                                                                                                                                                                               |           | (F)
|       
|       
|       
|       
|3.      | 4   |                     | Bylaws of Corixa Corporation                                                                                                                                                                                                                                         |           | (O)
|       
|       
|       
|       
|4.      | 1   |                     | Amended and Restated Investors Rights Agreement dated as of May 10, 1996 between
Corixa Corporation and certain holders of its capital stock                                                                                                                        |           | (A)
|       
|       
|       
|       
|10.     | 1   |                     | 2001 Stock Incentive Plan                                                                                                                                                                                                                                            |           | (M)
|       
|       
|       
|       
|10.     | 2   |                     | 1997 Directors Stock Option Plan and form of stock option agreement                                                                                                                                                                                                 |           | (A)
|       
|       
|       
|       
|10.     | 3   |                     | 2001 Employee Stock Purchase Plan and form of subscription agreement                                                                                                                                                                                                 |           | (N)
|       
|       
|       
|       
|10.     | 4   |                     | Corixa Corporation 401(k) Savings & Retirement Plan                                                                                                                                                                                                                  |           | (A)
|       
|       
|       
|       
|10.     | 5   |                     | Form of Indemnification Agreement between Corixa Corporation and each director and
officer of Corixa Corporation                                                                                                                                                     |           | (A)
|       
|       
|       
|       
|10.     | 6   |                     | Columbia Building Lease dated October 28, 1994 and Columbia Building Lease First
Amendment dated December 29, 1995, each between Corixa Corporation and Fred Hutchinson
Cancer Research Center                                                                       |           | (A)
|       
|       
|       
|       
|10.     | 7   |                     | Second Amendment to Columbia Building Lease dated as of September 25, 1998, between
Corixa Corporation and Alexandria Real Estate Equities, Inc., successor in interest to
Fred Hutchinson Cancer Research Center                                                    |           | (C)
|       
|       
|       
|       
|10.     | 8   |                     | Lease dated May 31, 1996 between Corixa Corporation and Health Science Properties, Inc.                                                                                                                                                                              |           | (A)
|       
|       
|       
|       
|10.     | 9   |                     | First Amendment to Lease dated January 31, 1997 between Corixa Corporation and Health
Science Properties, Inc.                                                                                                                                                       |           |   
|       
|       
|       
|       
|10.     | 10  |                     | Second Amendment to Lease dated June 30, 1997 between Corixa Corporation and Alexandria
Real Estate Equities, Inc., formerly known as Health Science Properties, Inc.                                                                                                |           |   
|       
|       
|       
|       
|10.     | 11  |                     | Third Amendment to Lease dated November 1, 1998 between Corixa Corporation and
Alexandria Real Estate Equities, Inc., formerly known as Health Science Properties,
Inc.                                                                                              |           |   
|       
|       
|       
|       
|10.     | 12+ |                     | Multi-Field Vaccine Discovery Collaboration and License Agreement between Corixa
Corporation and SmithKline Beecham plc, dated September 1, 1998                                                                                                                     |           | (D)
|       
|       
|       
|       
|10.     | 13+ |                     | Amendment No. 1, dated May 25, 2000, to the Multi-Field Vaccine Discovery Collaboration
and License Agreement, dated October 28, 1998, by and between Corixa Corporation and
SmithKline Beecham plc                                                                  |           | (L)
|       
|       
|       
|       
|10.     | 14* |                     | Letter Agreement, dated as of August 16, 2001, between Corixa Corporation and
SmithKline Beecham plc, regarding the Multi-Field Vaccine Discovery Collaboration and
License Agreement between Corixa Corporation and SmithKline Beecham plc, dated
September 1, 1998 |           |  

2



---



##### Table of Contents



|        |     |                     |                                                                                                                                                                                                                       |           |    
|------- | --- | ------------------- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | --------- | ---
|Exhibit |     |                     |                                                                                                                                                                                                                       |          
|Number  |     | Exhibit Description |                                                                                                                                                                                                                       | Reference
|        |     |                     |                                                                                                                                                                                                                       |          
|10.     | 15+ |                     | Equity Line of Credit and Securities Purchase Agreement between Corixa Corporation and
Castle Gate, L.L.C., dated April 8, 1999                                                                                       |           | (E)
|       
|       
|       
|       
|10.     | 16+ |                     | Registration Rights Agreement between Corixa Corporation and Castle Gate, L.L.C., dated
April 8, 1999                                                                                                                 |           | (E)
|       
|       
|       
|       
|10.     | 17+ |                     | Standstill Agreement between Corixa Corporation and Castle Gate, L.L.C., dated April 8,
1999                                                                                                                          |           | (E)
|       
|       
|       
|       
|10.     | 18+ |                     | Warrant Number CG-1 issued by Corixa Corporation to Castle Gate, L.L.C. on April 8, 1999                                                                                                                              |           | (E)
|       
|       
|       
|       
|10.     | 19+ |                     | Warrant Number CG-2 issued by Corixa Corporation to Castle Gate, L.L.C. on April 8, 1999                                                                                                                              |           | (E)
|       
|       
|       
|       
|10.     | 20+ |                     | Form of Warrant Number CG-3 to be issued by Corixa Corporation to Castle Gate, L.L.C.
on the occurrence of certain events in accordance with the terms of the Equity Line of
Credit and Securities Purchase Agreement |           | (E)
|       
|       
|       
|       
|10.     | 21+ |                     | Form of Warrant Number CG-4 to be issued by Corixa Corporation to Castle Gate, L.L.C.
on the occurrence of certain events in accordance with the terms of the Equity Line of
Credit and Securities Purchase Agreement |           | (E)
|       
|       
|       
|       
|10.     | 22+ |                     | Amendment No. 1, dated December 21, 2000, to the Equity Line of Credit and Securities
Purchase Agreement, dated April 8, 1999, by and between Corixa Corporation and Castle
Gate, L.L.C.                              |           | (F)
|       
|       
|       
|       
|10.     | 23+ |                     | Amendment No. 2, dated December 29, 2000, to the Equity Line of Credit and Securities
Purchase Agreement, dated April 8, 1999, by and between Corixa Corporation and Castle
Gate, L.L.C.                              |           | (F)
|       
|       
|       
|       
|10.     | 24+ |                     | Warrant Number CG-5 issued by Corixa Corporation to Castle Gate on December 29, 2000                                                                                                                                  |           | (F)
|       
|       
|       
|       
|10.     | 25+ |                     | Distribution and Supply Agreement, dated March 11, 1998, by and between Corixa
Corporation, Schering Corporation and RibiImmunoChem Research, Inc., as amended                                                        |           | (O)
|       
|       
|       
|       
|10.     | 26+ |                     | Distribution and Supply Agreement, dated March 11, 1998, by and between Corixa
Corporation, Schering-Plough Ltd. and RibiImmunoChem Research, Inc., as amended                                                        |           | (O)
|       
|       
|       
|       
|10.     | 27  |                     | Separation Agreement between Corixa Corporation and Mark McDade, dated November 27, 2000                                                                                                                              |           | (O)
|       
|       
|       
|       
|10.     | 28+ |                     | Development, Commercialization and License Agreement, dated August 15, 2000 by and
between Corixa Corporation and Medicis Pharmaceutical Corporation                                                                  |           | (L)
|       
|       
|       
|       
|10.     | 29  |                     | Coulter Pharmaceutical, Inc. 1996 Employee Stock Purchase Plan                                                                                                                                                        |           | (G)
|       
|       
|       
|       
|10.     | 30  |                     | Coulter Pharmaceutical, Inc. 1995 Equity Incentive Plan                                                                                                                                                               |           | (G)
|       
|       
|       
|       
|10.     | 31  |                     | Coulter Pharmaceutical, Inc. 1996 Equity Incentive Plan                                                                                                                                                               |           | (G)
|       
|       
|       
|       
|10.     | 32  |                     | Assignment Agreement between Coulter Pharmaceutical, Inc., Beckman Coulter and certain
investors, dated February 24, 1995                                                                                             |           | (H)
|       
|       
|       
|       
|10.     | 33+ |                     | Development Agreement between Coulter Pharmaceutical, Inc. and MDS Nordion Inc., dated
November 15, 1995                                                                                                              |           | (H)
|       
|       
|       
|       
|10.     | 34+ |                     | Contract Research and Development Agreement, by and between Coulter Pharmaceutical,
Inc. and Dr. Karl Thomas GmbH, dated October 22, 1997                                                                             |           | (I)
|       
|       
|       
|       
|10.     | 35+ |                     | Supply Agreement between Coulter Pharmaceutical, Inc. and MDS Nordion Inc., dated
August 31, 1998                                                                                                                     |           | (J)
|       
|       
|       
|       
|10.     | 36+ |                     | Facilities Agreement between Coulter Pharmaceutical, Inc. and MDS Nordion Inc., dated
August 31, 1998                                                                                                                 |           | (J)
|       
|       
|       
|       
|10.     | 37+ |                     | Security Agreement between Coulter Pharmaceutical, Inc. and SmithKline Beecham
Corporation, dated October 23, 1998                                                                                                    |           | (K)

3



---



##### Table of Contents



|        |     |                     |                                                                                                                                                                                                                                                       |           |    
|------- | --- | ------------------- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | --------- | ---
|Exhibit |     |                     |                                                                                                                                                                                                                                                       |          
|Number  |     | Exhibit Description |                                                                                                                                                                                                                                                       | Reference
|        |     |                     |                                                                                                                                                                                                                                                       |          
|10.     | 38+ |                     | Grant of Security Interest between Coulter Pharmaceutical, Inc. and SmithKline Beecham
Corporation, dated October 23, 1998                                                                                                                            |           | (K)
|       
|       
|       
|       
|10.     | 39+ |                     | Loan Agreement between Coulter Pharmaceutical, Inc. and SmithKline Beecham Corporation,
dated October 23, 1998                                                                                                                                        |           | (K)
|       
|       
|       
|       
|10.     | 40+ |                     | Collaboration Agreement between Coulter Pharmaceutical, Inc. and SmithKline Beecham
Corporation, dated October 23, 1998                                                                                                                               |           | (K)
|       
|       
|       
|       
|10.     | 41+ |                     | Amendment No. 1, dated November 30, 1998, to the Collaboration Agreement between
Coulter Pharmaceutical, Inc. and SmithKline Beecham, dated October 23, 1998                                                                                          |           | (K)
|       
|       
|       
|       
|10.     | 42* |                     | Letter Agreement between Coulter Pharmaceutical, Inc. and SmithKline Beecham
Corporation, dated April 20, 2000, regarding the Collaboration Agreement between
Coulter Pharmaceutical, Inc. and SmithKline Beecham Corporation, dated October 23, 1998 |           |  
|       
|       
|       
|       
|10.     | 43* |                     | Letter Agreement between Corixa Corporation and SmithKline Beecham Corporation, dated
February 12, 2001, regarding the Collaboration Agreement between Coulter
Pharmaceutical, Inc. and SmithKline Beecham Corporation, dated October 23, 1998        |           |  
|       
|       
|       
|       
|10.     | 44* |                     | Letter Agreement between Corixa Corporation and SmithKline Beecham Corporation, dated
October 18, 2001, regarding the Collaboration Agreement between Coulter Pharmaceutical,
Inc. and SmithKline Beecham Corporation, dated October 23, 1998         |           |  
|       
|       
|       
|       
|10.     | 45+ |                     | Supply Agreement between Coulter Pharmaceutical, Inc and Boehringer Ingelheim Pharma
KG, dated November 3, 1998                                                                                                                                       |           | (K)
|       
|       
|       
|       
|10.     | 46  |                     | Satisfaction Agreement, dated June 28, 2001 between Michael F. Bigham and Corixa
Corporation                                                                                                                                                          |           | (N)
|       
|       
|       
|       
|10.     | 47  |                     | Consulting Agreement, dated June 28, 2001 between Michael F. Bigham and Corixa
Corporation                                                                                                                                                            |           | (N)
|       
|       
|       
|       
|10.     | 48  |                     | Form of Bexxar Stock Award Agreement, dated October 15, 2000 between Corixa Corporation
and certain directors and officers of Corixa Corporation                                                                                                      |           | (N)
|       
|       
|       
|       
|10.     | 49  |                     | Schedule of officers and directors of Corixa Corporation party to Bexxar Stock Award
Agreement                                                                                                                                                        |           | (N)
|       
|       
|       
|       
|10.     | 50  |                     | Form of Corixa Corporation Executive Employment Agreement                                                                                                                                                                                             |           | (N)
|       
|       
|       
|       
|10.     | 51  |                     | Schedule of officers party to Corixa Corporation Executive Employment Agreement                                                                                                                                                                       |           | (N)
|       
|       
|       
|       
|10.     | 52* |                     | Development, Commercialization and License Agreement dated October 29, 2001 between
Corixa Corporation and Amersham PLC                                                                                                                               |           | (P)
|       
|       
|       
|       
|10.     | 53* |                     | Manufacturing and Supply Agreement dated October 29, 2001 between Corixa Corporation
and Amersham PLC                                                                                                                                                 |           | (P)
|       
|       
|       
|       
|10.     | 54* |                     | Stock Purchase Agreement dated October 29, 2001 between Corixa Corporation and Amersham
Health, Inc.                                                                                                                                                  |           | (P)
|       
|       
|       
|       
|10.     | 55  |                     | Private Equity Line Financing Agreement dated December 3, 2001 between Corixa
Corporation and BNY Capital Markets, Inc.                                                                                                                               |           | (P)
|       
|       
|       
|       
|10.     | 56  |                     | Registration Rights Agreement dated December 3, 2001 between Corixa Corporation and BNY
Capital Markets, Inc.                                                                                                                                         |           | (P)
|       
|       
|       
|       
|10.     | 57  |                     | Form of warrant issued by Corixa Corporation to employees of Shoreline Pacific, LLC on
December 3, 2001                                                                                                                                               |           | (P)
|       
|       
|       
|       
|10.     | 58  |                     | Secured
Promissory Note by Steven G. Reed, Ph.D. and Marianne T. Reed in favor of Corixa Corporation, dated December 31, 2001                                                                                                                         |           |   

4



---



##### Table of Contents



|        |     |                     |                                                                                                                                                                                                                                 |           |    
|------- | --- | ------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | --------- | ---
|Exhibit |     |                     |                                                                                                                                                                                                                                 |          
|Number  |     | Exhibit Description |                                                                                                                                                                                                                                 | Reference
|        |     |                     |                                                                                                                                                                                                                                 |          
|10.     | 59  |                     | Secured Promissory Note by Kenneth A. Grabstein, Ph.D. and Teresa A. Grabstein in favor
of Corixa Corporation, dated December 31, 2001                                                                                          |           |   
|       
|       
|       
|       
|10.     | 60  |                     | Loan Agreement between Corixa Corporation and BNP Paribas, dated as of August 3, 2001                                                                                                                                           |           |   
|       
|       
|       
|       
|10.     | 61+ |                     | Collaboration Agreement dated May 21, 1999 between Corixa Corporation and Inpharzam
International                                                                                                                               |           | (R)
|       
|       
|       
|       
|10.     | 62+ |                     | License and Collaborative Research Agreement dated June 15, 1999 between Corixa
Corporation and Japan Tobacco Inc.                                                                                                              |           | (R)
|       
|       
|       
|       
|10.     | 63+ |                     | Research Agreement dated March 26, 1999 between Corixa Corporation and the Infectious
Disease Research Institute                                                                                                                |           | (Q)
|       
|       
|       
|       
|10.     | 64* |                     | Development and License Agreement dated August 16, 1999 between Zenyaku Kogyo Co., Ltd.
and Corixa Corporation                                                                                                                  |           |  
|       
|       
|       
|       
|10.     | 65  |                     | First Amendment dated February 28, 2002 to Private Equity Line Financing Agreement
dated as of December 3, 2001, between Corixa Corporation and BNY Capital Markets, Inc.                                                       |           |   
|       
|       
|       
|       
|10.     | 66  |                     | First Amendment dated February 28, 2002 to Registration Rights Agreement dated as of
December 3, 2001, between Corixa Corporation and BNY Capital Markets, Inc.                                                                 |           |   
|       
|       
|       
|       
|10.     | 67* |                     | Letter Agreement between Corixa Corporation and Zenyaku Kogyo Co., Ltd, dated August 6,
2001, regarding the Development and License Agreement between Corixa Corporation and
Zenyaku Kogyo Co., dated August 16, 1999           |           |  
|       
|       
|       
|       
|10.     | 68* |                     | Letter Agreement between Corixa Corporation and Japan Tobacco Inc., dated September 28,
2001, regarding the license and Collaborative Research Agreement between Corixa
Corporation and Japan Tobacco Inc., dated June 15, 1999 |           |  
|       
|       
|       
|       
|10.     | 69+ |                     | Lease dated November 7, 1997 between HMS Gateway Office L.P. and Coulter
Pharmaceutical, Inc.                                                                                                                                   |           | (K)
|       
|       
|       
|       
|10.     | 70+ |                     | First Amendment to Lease dated November 10, 1998 between HMS Gateway Office L.P. and
Coulter Pharmaceutical, Inc.                                                                                                               |           | (S)
|       
|       
|       
|       
|10.     | 71  |                     | Second Amendment to Lease dated May 19, 2000 between HMS Gateway Office L.P. and
Coulter Pharmaceutical, Inc.                                                                                                                   |           |   
|       
|       
|       
|       
|10.     | 72* |                     | Lease dated May 19, 2000 between HMS Gateway Office L.P. and Coulter Pharmaceutical,
Inc.                                                                                                                                       |           |  
|       
|       
|       
|       
|21.     | 1   |                     | Subsidiaries of Corixa Corporation                                                                                                                                                                                              |           |   
|       
|       
|       
|       
|23.     | 1   |                     | Consent of Ernst and Young, LLP, Independent Auditors                                                                                                                                                                           |           |   
|       
|       
|       
|       
|24.     | 1   |                     | Power of Attorney                                                                                                                                                                                                               |           |   



---

|(A) |  | Incorporated herein by reference Corixas Form S-1, as amended, (File No.
333-32147), filed with the Commission on September 30, 1997.
|--- |  | --------------------------------------------------------------------------------------------------------------------------------------
|   
|   
|   
|   
|(B) |  | Incorporated herein by reference to Corixas Form 10-Q (File No.
333-32147), filed with the Commission on August 11, 1998.            
|   
|   
|   
|   
|(C) |  | Incorporated herein by reference to Corixas Form 10-Q (File No.
333-32147), filed with the Commission on November 12, 1998.          
|   
|   
|   
|   
|(D) |  | Incorporated herein by reference to Corixas Form 8-K (File No. 0-22891),
filed with the Commission on November 10, 1998.             
|   
|   
|   
|   
|(E) |  | Incorporated herein by reference to Corixas Form 8-K (File No. 0-22891),
filed with the Commission on April 23, 1999.                
|   
|   
|   
|   
|(F) |  | Incorporated herein by reference to Corixas Form 8-K (File No. 0-22891),
filed with the Commission on January 4, 2001.               

5



---



##### Table of Contents



|(G) |  | Incorporated herein by reference to Corixas Registration Statement on
Form S-8 (File No. 333-52968), filed with the Commission on December 29,
2000.                                   
|--- |  | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|   
|   
|   
|   
|(H) |  | Incorporated herein by reference to Coulter Pharmaceutical, Inc.s
Registration Statement on Form S-1 (File No. 333-17661), as amended, filed
with the Commission on September 29, 1997.
|   
|   
|   
|   
|(I) |  | Incorporated herein by reference to Coulter Pharmaceutical, Inc.s Form
10-K (File No. 000-21905), filed with the Commission on March 27, 1998.                                         
|   
|   
|   
|   
|(J) |  | Incorporated herein by reference to Coulter Pharmaceutical, Inc.s Form
10-Q (File No. 000-21905), filed with the Commission on November 13, 1998.                                      
|   
|   
|   
|   
|(K) |  | Incorporated herein by reference to Coulter Pharmaceutical, Inc.s Form
10-K,(File No. 000-21905), filed with the Commission on March 30, 1999.                                         
|   
|   
|   
|   
|(L) |  | Incorporated herein by reference to Corixas Form 10-Q (File No.
000-22891), filed with the Commission on November 6, 2000.                                                             
|   
|   
|   
|   
|(M) |  | Incorporated herein by reference to Corixas Registration Statement on
Form S-8 (File No. 333-65394), filed with the Commission on July 19, 2001.                                       
|   
|   
|   
|   
|(N) |  | Incorporated herein by reference to Corixas Form 10-Q (File No.
000-22891), filed with the Commission on November 13, 2001.                                                            
|   
|   
|   
|   
|(O) |  | Incorporated herein by reference to Corixas Form 10-K (File No.
000-22891), filed with the Commission on March 30, 2001.                                                               
|   
|   
|   
|   
|(P) |  | Incorporated herein by reference to Corixas Form 8-K (File No.
000-22891), filed with the Commission on December 17, 2001.                                                             
|   
|   
|   
|   
|(Q) |  | Incorporated herein by reference to Corixas Form 10-Q (File No.
000-22891), filed with the Commission on May 6, 1999.                                                                  
|   
|   
|   
|   
|(R) |  | Incorporated herein by reference to Corixas Form 10-Q (File No.
000-22891), filed with the Commission on August 9, 1999.                                                               
|   
|   
|   
|   
|(S) |  | Incorporated herein by reference to Coulter Pharmaceutical, Inc.s Form
10-K405 (File No. 000-21905), filed with the Commission on March 30, 1999.                                      
|   
|+   |  | Confidential treatment granted by order of the SEC.                                                                                                                                     
|   
|   
|   
|   
|*   |  | Confidential treatment sought by Corixa Corporation from the SEC.                                                                                                                       
|   
|   
|   
|   
|   |  | Previously filed.                                                                                                                                                                       
|   
|   
|   
|   
|  |  | Filed herewith.                                                                                                                                                                         

6



---



##### Table of Contents






SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this amended report to be signed on its behalf by
the undersigned, thereunto duly authorized.

| |                    |                                                          
| | ------------------ | ---------------------------------------------------------
| | CORIXA CORPORATION
|
| | By:                | /s/   MICHELLE
BURRIS                                    
| |                    | Michelle BurrisVice President and Chief Financial Officer

Date: June 24, 2002

Pursuant to the requirements of the Securities Exchange Act of 1934, this
amended report has been signed by the following persons in the capacities
indicated below on the 24th day of June, 2002.

|                                     |                                                       |                                                                                                |          | 
|------------------------------------ | ----------------------------------------------------- | ---------------------------------------------------------------------------------------------- | -------- | 
|Signature                            |                                                       | Title                                                                                         
|                                     |                                                       |                                                                                               
|                                    
|/s/  STEVEN GILLISSteven Gillis      |                                                       | Chairman and Chief Executive Officer
(Principal Executive Officer)                            
|                                    
|/s/   MICHELLE
BURRISMichelle Burris |                                                       | Senior Vice President and Chief Financial Officer
(Principal Financial and Accounting Officer)
|                                    
|MARK MCDADE*
Mark McDade             |                                                       | Director                                                                                      
|                                    
|MICHAEL F. BIGHAM*
Michael F. Bigham |                                                       | Director                                                                                      
|                                    
|JOSEPH L. LACOB*
Joseph L. Lacob     |                                                       | Director                                                                                      
|                                    
|ARNOLD ORONSKY*
Arnold Oronsky       |                                                       | Director                                                                                      
|                                    
|JAMES YOUNG*
James Young             |                                                       | Director                                                                                      
|                                    
|ROBERT MOMSEN*
Robert Momsen         |                                                       | Director                                                                                      
|                                    
|SAMUEL R. SAKS*
Samuel R. Saks       |                                                       | Director                                                                                      
|                                    
|*By:                                 | /s/   MICHELLE
BURRISMichelle Burris
Attorney-in-Fact |                                                                                                | Director

7



---



##### Table of Contents






INDEX TO EXHIBITS

|        |     |                     |                                                                                                                                                                                                                                                                      |           |    
|------- | --- | ------------------- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | --------- | ---
|Exhibit |     |                     |                                                                                                                                                                                                                                                                      |          
|Number  |     | Exhibit Description |                                                                                                                                                                                                                                                                      | Reference
|        |     |                     |                                                                                                                                                                                                                                                                      |          
|3.      | 1   |                     | Amended and Restated Certificate of Incorporation of Corixa Corporation                                                                                                                                                                                              |           | (A)
|       
|       
|       
|       
|3.      | 2   |                     | Certificate of Designation of Series A Preferred Stock                                                                                                                                                                                                               |           | (E)
|       
|       
|       
|       
|3.      | 3   |                     | Certificate of Designation of Series B Preferred Stock                                                                                                                                                                                                               |           | (F)
|       
|       
|       
|       
|3.      | 4   |                     | Bylaws of Corixa Corporation                                                                                                                                                                                                                                         |           | (O)
|       
|       
|       
|       
|4.      | 1   |                     | Amended and Restated Investors Rights Agreement dated as of May 10, 1996 between
Corixa Corporation and certain holders of its capital stock                                                                                                                        |           | (A)
|       
|       
|       
|       
|10.     | 1   |                     | 2001 Stock Incentive Plan                                                                                                                                                                                                                                            |           | (M)
|       
|       
|       
|       
|10.     | 2   |                     | 1997 Directors Stock Option Plan and form of stock option agreement                                                                                                                                                                                                 |           | (A)
|       
|       
|       
|       
|10.     | 3   |                     | 2001 Employee Stock Purchase Plan and form of subscription agreement                                                                                                                                                                                                 |           | (N)
|       
|       
|       
|       
|10.     | 4   |                     | Corixa Corporation 401(k) Savings & Retirement Plan                                                                                                                                                                                                                  |           | (A)
|       
|       
|       
|       
|10.     | 5   |                     | Form of Indemnification Agreement between Corixa Corporation and each director and
officer of Corixa Corporation                                                                                                                                                     |           | (A)
|       
|       
|       
|       
|10.     | 6   |                     | Columbia Building Lease dated October 28, 1994 and Columbia Building Lease First
Amendment dated December 29, 1995, each between Corixa Corporation and Fred Hutchinson
Cancer Research Center                                                                       |           | (A)
|       
|       
|       
|       
|10.     | 7   |                     | Second Amendment to Columbia Building Lease dated as of September 25, 1998, between
Corixa Corporation and Alexandria Real Estate Equities, Inc., successor in interest to
Fred Hutchinson Cancer Research Center                                                    |           | (C)
|       
|       
|       
|       
|10.     | 8   |                     | Lease dated May 31, 1996 between Corixa Corporation and Health Science Properties, Inc.                                                                                                                                                                              |           | (A)
|       
|       
|       
|       
|10.     | 9   |                     | First Amendment to Lease dated January 31, 1997 between Corixa Corporation and Health
Science Properties, Inc.                                                                                                                                                       |           |   
|       
|       
|       
|       
|10.     | 10  |                     | Second Amendment to Lease dated June 30, 1997 between Corixa Corporation and Alexandria
Real Estate Equities, Inc., formerly known as Health Science Properties, Inc.                                                                                                |           |   
|       
|       
|       
|       
|10.     | 11  |                     | Third Amendment to Lease dated November 1, 1998 between Corixa Corporation and
Alexandria Real Estate Equities, Inc., formerly known as Health Science Properties,
Inc.                                                                                              |           |   
|       
|       
|       
|       
|10.     | 12+ |                     | Multi-Field Vaccine Discovery Collaboration and License Agreement between Corixa
Corporation and SmithKline Beecham plc, dated September 1, 1998                                                                                                                     |           | (D)
|       
|       
|       
|       
|10.     | 13+ |                     | Amendment No. 1, dated May 25, 2000, to the Multi-Field Vaccine Discovery Collaboration
and License Agreement, dated October 28, 1998, by and between Corixa Corporation and
SmithKline Beecham plc                                                                  |           | (L)
|       
|       
|       
|       
|10.     | 14* |                     | Letter Agreement, dated as of August 16, 2001, between Corixa Corporation and
SmithKline Beecham plc, regarding the Multi-Field Vaccine Discovery Collaboration and
License Agreement between Corixa Corporation and SmithKline Beecham plc, dated
September 1, 1998 |           |  
|       
|       
|       
|       
|10.     | 15+ |                     | Equity Line of Credit and Securities Purchase Agreement between Corixa Corporation and
Castle Gate, L.L.C., dated April 8, 1999                                                                                                                                      |           | (E)
|       
|       
|       
|       
|10.     | 16+ |                     | Registration Rights Agreement between Corixa Corporation and Castle Gate, L.L.C., dated
April 8, 1999                                                                                                                                                                |           | (E)
|       
|       
|       
|       
|10.     | 17+ |                     | Standstill Agreement between Corixa Corporation and Castle Gate, L.L.C., dated April 8,
1999                                                                                                                                                                         |           | (E)
|       
|       
|       
|       
|10.     | 18+ |                     | Warrant Number CG-1 issued by Corixa Corporation to Castle Gate, L.L.C. on April 8, 1999                                                                                                                                                                             |           | (E)

8



---



##### Table of Contents



|        |     |                     |                                                                                                                                                                                                                       |           |    
|------- | --- | ------------------- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | --------- | ---
|Exhibit |     |                     |                                                                                                                                                                                                                       |          
|Number  |     | Exhibit Description |                                                                                                                                                                                                                       | Reference
|        |     |                     |                                                                                                                                                                                                                       |          
|10.     | 19+ |                     | Warrant Number CG-2 issued by Corixa Corporation to Castle Gate, L.L.C. on April 8, 1999                                                                                                                              |           | (E)
|       
|       
|       
|       
|10.     | 20+ |                     | Form of Warrant Number CG-3 to be issued by Corixa Corporation to Castle Gate, L.L.C.
on the occurrence of certain events in accordance with the terms of the Equity Line of
Credit and Securities Purchase Agreement |           | (E)
|       
|       
|       
|       
|10.     | 21+ |                     | Form of Warrant Number CG-4 to be issued by Corixa Corporation to Castle Gate, L.L.C.
on the occurrence of certain events in accordance with the terms of the Equity Line of
Credit and Securities Purchase Agreement |           | (E)
|       
|       
|       
|       
|10.     | 22+ |                     | Amendment No. 1, dated December 21, 2000, to the Equity Line of Credit and Securities
Purchase Agreement, dated April 8, 1999, by and between Corixa Corporation and Castle
Gate, L.L.C.                              |           | (F)
|       
|       
|       
|       
|10.     | 23+ |                     | Amendment No. 2, dated December 29, 2000, to the Equity Line of Credit and Securities
Purchase Agreement, dated April 8, 1999, by and between Corixa Corporation and Castle
Gate, L.L.C.                              |           | (F)
|       
|       
|       
|       
|10.     | 24+ |                     | Warrant Number CG-5 issued by Corixa Corporation to Castle Gate on December 29, 2000                                                                                                                                  |           | (F)
|       
|       
|       
|       
|10.     | 25+ |                     | Distribution and Supply Agreement, dated March 11, 1998, by and between Corixa
Corporation, Schering Corporation and RibiImmunoChem Research, Inc., as amended                                                        |           | (O)
|       
|       
|       
|       
|10.     | 26+ |                     | Distribution and Supply Agreement, dated March 11, 1998, by and between Corixa
Corporation, Schering-Plough Ltd. and RibiImmunoChem Research, Inc., as amended                                                        |           | (O)
|       
|       
|       
|       
|10.     | 27  |                     | Separation Agreement between Corixa Corporation and Mark McDade, dated November 27, 2000                                                                                                                              |           | (O)
|       
|       
|       
|       
|10.     | 28+ |                     | Development, Commercialization and License Agreement, dated August 15, 2000 by and
between Corixa Corporation and Medicis Pharmaceutical Corporation                                                                  |           | (L)
|       
|       
|       
|       
|10.     | 29  |                     | Coulter Pharmaceutical, Inc. 1996 Employee Stock Purchase Plan                                                                                                                                                        |           | (G)
|       
|       
|       
|       
|10.     | 30  |                     | Coulter Pharmaceutical, Inc. 1995 Equity Incentive Plan                                                                                                                                                               |           | (G)
|       
|       
|       
|       
|10.     | 31  |                     | Coulter Pharmaceutical, Inc. 1996 Equity Incentive Plan                                                                                                                                                               |           | (G)
|       
|       
|       
|       
|10.     | 32  |                     | Assignment Agreement between Coulter Pharmaceutical, Inc., Beckman Coulter and certain
investors, dated February 24, 1995                                                                                             |           | (H)
|       
|       
|       
|       
|10.     | 33+ |                     | Development Agreement between Coulter Pharmaceutical, Inc. and MDS Nordion Inc., dated
November 15, 1995                                                                                                              |           | (H)
|       
|       
|       
|       
|10.     | 34+ |                     | Contract Research and Development Agreement, by and between Coulter Pharmaceutical,
Inc. and Dr. Karl Thomas GmbH, dated October 22, 1997                                                                             |           | (I)
|       
|       
|       
|       
|10.     | 35+ |                     | Supply Agreement between Coulter Pharmaceutical, Inc. and MDS Nordion Inc., dated
August 31, 1998                                                                                                                     |           | (J)
|       
|       
|       
|       
|10.     | 36+ |                     | Facilities Agreement between Coulter Pharmaceutical, Inc. and MDS Nordion Inc., dated
August 31, 1998                                                                                                                 |           | (J)
|       
|       
|       
|       
|10.     | 37+ |                     | Security Agreement between Coulter Pharmaceutical, Inc. and SmithKline Beecham
Corporation, dated October 23, 1998                                                                                                    |           | (K)
|       
|       
|       
|       
|10.     | 38+ |                     | Grant of Security Interest between Coulter Pharmaceutical, Inc. and SmithKline Beecham
Corporation, dated October 23, 1998                                                                                            |           | (K)
|       
|       
|       
|       
|10.     | 39+ |                     | Loan Agreement between Coulter Pharmaceutical, Inc. and SmithKline Beecham Corporation,
dated October 23, 1998                                                                                                        |           | (K)
|       
|       
|       
|       
|10.     | 40+ |                     | Collaboration Agreement between Coulter Pharmaceutical, Inc. and SmithKline Beecham
Corporation, dated October 23, 1998                                                                                               |           | (K)

9



---



##### Table of Contents



|        |     |                     |                                                                                                                                                                                                                                                       |           |    
|------- | --- | ------------------- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | --------- | ---
|Exhibit |     |                     |                                                                                                                                                                                                                                                       |          
|Number  |     | Exhibit Description |                                                                                                                                                                                                                                                       | Reference
|        |     |                     |                                                                                                                                                                                                                                                       |          
|10.     | 41+ |                     | Amendment No. 1, dated November 30, 1998, to the Collaboration Agreement between
Coulter Pharmaceutical, Inc. and SmithKline Beecham, dated October 23, 1998                                                                                          |           | (K)
|       
|       
|       
|       
|10.     | 42* |                     | Letter Agreement between Coulter Pharmaceutical, Inc. and SmithKline Beecham
Corporation, dated April 20, 2000, regarding the Collaboration Agreement between
Coulter Pharmaceutical, Inc. and SmithKline Beecham Corporation, dated October 23, 1998 |           |  
|       
|       
|       
|       
|10.     | 43* |                     | Letter Agreement between Corixa Corporation and SmithKline Beecham Corporation, dated
February 12, 2001, regarding the Collaboration Agreement between Coulter
Pharmaceutical, Inc. and SmithKline Beecham Corporation, dated October 23, 1998        |           |  
|       
|       
|       
|       
|10.     | 44* |                     | Letter Agreement between Corixa Corporation and SmithKline Beecham Corporation, dated
October 18, 2001, regarding the Collaboration Agreement between Coulter Pharmaceutical,
Inc. and SmithKline Beecham Corporation, dated October 23, 1998         |           |  
|       
|       
|       
|       
|10.     | 45+ |                     | Supply Agreement between Coulter Pharmaceutical, Inc and Boehringer Ingelheim Pharma
KG, dated November 3, 1998                                                                                                                                       |           | (K)
|       
|       
|       
|       
|10.     | 46  |                     | Satisfaction Agreement, dated June 28, 2001 between Michael F. Bigham and Corixa
Corporation                                                                                                                                                          |           | (N)
|       
|       
|       
|       
|10.     | 47  |                     | Consulting Agreement, dated June 28, 2001 between Michael F. Bigham and Corixa
Corporation                                                                                                                                                            |           | (N)
|       
|       
|       
|       
|10.     | 48  |                     | Form of Bexxar Stock Award Agreement, dated October 15, 2000 between Corixa Corporation
and certain directors and officers of Corixa Corporation                                                                                                      |           | (N)
|       
|       
|       
|       
|10.     | 49  |                     | Schedule of officers and directors of Corixa Corporation party to Bexxar Stock Award
Agreement                                                                                                                                                        |           | (N)
|       
|       
|       
|       
|10.     | 50  |                     | Form of Corixa Corporation Executive Employment Agreement                                                                                                                                                                                             |           | (N)
|       
|       
|       
|       
|10.     | 51  |                     | Schedule of officers party to Corixa Corporation Executive Employment Agreement                                                                                                                                                                       |           | (N)
|       
|       
|       
|       
|10.     | 52* |                     | Development, Commercialization and License Agreement dated October 29, 2001 between
Corixa Corporation and Amersham PLC                                                                                                                               |           | (P)
|       
|       
|       
|       
|10.     | 53* |                     | Manufacturing and Supply Agreement dated October 29, 2001 between Corixa Corporation
and Amersham PLC                                                                                                                                                 |           | (P)
|       
|       
|       
|       
|10.     | 54* |                     | Stock Purchase Agreement dated October 29, 2001 between Corixa Corporation and Amersham
Health, Inc.                                                                                                                                                  |           | (P)
|       
|       
|       
|       
|10.     | 55  |                     | Private Equity Line Financing Agreement dated December 3, 2001 between Corixa
Corporation and BNY Capital Markets, Inc.                                                                                                                               |           | (P)
|       
|       
|       
|       
|10.     | 56  |                     | Registration Rights Agreement dated December 3, 2001 between Corixa Corporation and BNY
Capital Markets, Inc.                                                                                                                                         |           | (P)
|       
|       
|       
|       
|10.     | 57  |                     | Form of warrant issued by Corixa Corporation to employees of Shoreline Pacific, LLC on
December 3, 2001                                                                                                                                               |           | (P)
|       
|       
|       
|       
|10.     | 58  |                     | Secured
Promissory Note by Steven G. Reed, Ph.D. and Marianne T. Reed in favor of Corixa Corporation, dated December 31, 2001                                                                                                                         |           |   
|       
|       
|       
|       
|10.     | 59  |                     | Secured Promissory Note by Kenneth A. Grabstein, Ph.D. and Teresa A. Grabstein in favor
of Corixa Corporation, dated December 31, 2001                                                                                                                |           |   
|       
|       
|       
|       
|10.     | 60  |                     | Loan Agreement between Corixa Corporation and BNP Paribas, dated as of August 3, 2001                                                                                                                                                                 |           |   
|       
|       
|       
|       
|10.     | 61+ |                     | Collaboration Agreement dated May 21, 1999 between Corixa Corporation and Inpharzam
International                                                                                                                                                     |           | (R)
|       
|       
|       
|       
|10.     | 62+ |                     | License and Collaborative Research Agreement dated June 15, 1999 between Corixa
Corporation and Japan Tobacco Inc.                                                                                                                                    |           | (R)

10



---



##### Table of Contents



|        |     |                     |                                                                                                                                                                                                                                 |           |    
|------- | --- | ------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | --------- | ---
|Exhibit |     |                     |                                                                                                                                                                                                                                 |          
|Number  |     | Exhibit Description |                                                                                                                                                                                                                                 | Reference
|        |     |                     |                                                                                                                                                                                                                                 |          
|10.     | 63+ |                     | Research Agreement dated March 26, 1999 between Corixa Corporation and the Infectious
Disease Research Institute                                                                                                                |           | (Q)
|       
|       
|       
|       
|10.     | 64* |                     | Development and License Agreement dated August 16, 1999 between Zenyaku Kogyo Co., Ltd.
and Corixa Corporation                                                                                                                  |           |  
|       
|       
|       
|       
|10.     | 65  |                     | First Amendment dated February 28, 2002 to Private Equity Line Financing Agreement
dated as of December 3, 2001, between Corixa Corporation and BNY Capital Markets, Inc.                                                       |           |   
|       
|       
|       
|       
|10.     | 66  |                     | First Amendment dated February 28, 2002 to Registration Rights Agreement dated as of
December 3, 2001, between Corixa Corporation and BNY Capital Markets, Inc.                                                                 |           |   
|       
|       
|       
|       
|10.     | 67* |                     | Letter Agreement between Corixa Corporation and Zenyaku Kogyo Co., Ltd, dated August 6,
2001, regarding the Development and License Agreement between Corixa Corporation and
Zenyaku Kogyo Co., dated August 16, 1999           |           |  
|       
|       
|       
|       
|10.     | 68* |                     | Letter Agreement between Corixa Corporation and Japan Tobacco Inc., dated September 28,
2001, regarding the license and Collaborative Research Agreement between Corixa
Corporation and Japan Tobacco Inc., dated June 15, 1999 |           |  
|       
|       
|       
|       
|10.     | 69+ |                     | Lease dated November 7, 1997 between HMS Gateway Office L.P. and Coulter
Pharmaceutical, Inc.                                                                                                                                   |           | (K)
|       
|       
|       
|       
|10.     | 70+ |                     | First Amendment to Lease dated November 10, 1998 between HMS Gateway Office L.P. and
Coulter Pharmaceutical, Inc.                                                                                                               |           | (S)
|       
|       
|       
|       
|10.     | 71  |                     | Second Amendment to Lease dated May 19, 2000 between HMS Gateway Office L.P. and
Coulter Pharmaceutical, Inc.                                                                                                                   |           |   
|       
|       
|       
|       
|10.     | 72* |                     | Lease dated May 19, 2000 between HMS Gateway Office L.P. and Coulter Pharmaceutical,
Inc.                                                                                                                                       |           |  
|       
|       
|       
|       
|21.     | 1   |                     | Subsidiaries of Corixa Corporation                                                                                                                                                                                              |           |   
|       
|       
|       
|       
|23.     | 1   |                     | Consent of Ernst and Young, LLP, Independent Auditors                                                                                                                                                                           |           |   
|       
|       
|       
|       
|24.     | 1   |                     | Power of Attorney                                                                                                                                                                                                               |           |   



---

|(A) |  | Incorporated herein by reference Corixas Form S-1, as amended, (File No.
333-32147), filed with the Commission on September 30, 1997.                                                  
|--- |  | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|   
|   
|   
|   
|(B) |  | Incorporated herein by reference to Corixas Form 10-Q (File No.
333-32147), filed with the Commission on August 11, 1998.                                                              
|   
|   
|   
|   
|(C) |  | Incorporated herein by reference to Corixas Form 10-Q (File No.
333-32147), filed with the Commission on November 12, 1998.                                                            
|   
|   
|   
|   
|(D) |  | Incorporated herein by reference to Corixas Form 8-K (File No. 0-22891),
filed with the Commission on November 10, 1998.                                                               
|   
|   
|   
|   
|(E) |  | Incorporated herein by reference to Corixas Form 8-K (File No. 0-22891),
filed with the Commission on April 23, 1999.                                                                  
|   
|   
|   
|   
|(F) |  | Incorporated herein by reference to Corixas Form 8-K (File No. 0-22891),
filed with the Commission on January 4, 2001.                                                                 
|   
|   
|   
|   
|(G) |  | Incorporated herein by reference to Corixas Registration Statement on
Form S-8 (File No. 333-52968), filed with the Commission on December 29,
2000.                                   
|   
|   
|   
|   
|(H) |  | Incorporated herein by reference to Coulter Pharmaceutical, Inc.s
Registration Statement on Form S-1 (File No. 333-17661), as amended, filed
with the Commission on September 29, 1997.
|   
|   
|   
|   
|(I) |  | Incorporated herein by reference to Coulter Pharmaceutical, Inc.s Form
10-K (File No. 000-21905), filed with the Commission on March 27, 1998.                                         

11



---



##### Table of Contents



|(J) |  | Incorporated herein by reference to Coulter Pharmaceutical, Inc.s Form
10-Q (File No. 000-21905), filed with the Commission on November 13, 1998.
|--- |  | --------------------------------------------------------------------------------------------------------------------------------------------------
|   
|   
|   
|   
|(K) |  | Incorporated herein by reference to Coulter Pharmaceutical, Inc.s Form
10-K,(File No. 000-21905), filed with the Commission on March 30, 1999.   
|   
|   
|   
|   
|(L) |  | Incorporated herein by reference to Corixas Form 10-Q (File No.
000-22891), filed with the Commission on November 6, 2000.                       
|   
|   
|   
|   
|(M) |  | Incorporated herein by reference to Corixas Registration Statement on
Form S-8 (File No. 333-65394), filed with the Commission on July 19, 2001. 
|   
|   
|   
|   
|(N) |  | Incorporated herein by reference to Corixas Form 10-Q (File No.
000-22891), filed with the Commission on November 13, 2001.                      
|   
|   
|   
|   
|(O) |  | Incorporated herein by reference to Corixas Form 10-K (File No.
000-22891), filed with the Commission on March 30, 2001.                         
|   
|   
|   
|   
|(P) |  | Incorporated herein by reference to Corixas Form 8-K (File No.
000-22891), filed with the Commission on December 17, 2001.                       
|   
|   
|   
|   
|(Q) |  | Incorporated herein by reference to Corixas Form 10-Q (File No.
000-22891), filed with the Commission on May 6, 1999.                            
|   
|   
|   
|   
|(R) |  | Incorporated herein by reference to Corixas Form 10-Q (File No.
000-22891), filed with the Commission on August 9, 1999.                         
|   
|   
|   
|   
|(S) |  | Incorporated herein by reference to Coulter Pharmaceutical, Inc.s Form
10-K405 (File No. 000-21905), filed with the Commission on March 30, 1999.
|   
|+   |  | Confidential treatment granted by order of the SEC.                                                                                               
|   
|   
|   
|   
|*   |  | Confidential treatment sought by Corixa Corporation from the SEC.                                                                                 
|   
|   
|   
|   
|   |  | Previously filed.                                                                                                                                 
|   
|   
|   
|   
|  |  | Filed herewith.                                                                                                                                   

12